Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$625,190,761
+$34,122,912 QoQ
Shares Held
13,041,109
-18.9% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#3
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. NVO ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $625,190,761 | 13,041,109 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $591,067,849 | 16,083,479 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $748,063,602 | 14,702,508 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $776,015,937 | 13,984,789 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $22,495,133 | 325,922 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $33,747,976 | 486,002 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $42,758,906 | 497,081 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $104,286,504 | 875,842 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $125,646,454 | 880,247 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $79,603,889 | 619,968 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $56,392,455 | 545,118 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $49,784,011 | 547,438 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $47,166,809 | 291,459 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $49,326,873 | 309,959 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $43,605,734 | 322,194 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $32,363,808 | 324,840 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,378,662 | 326,471 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $38,078,710 | 342,897 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $39,528,272 | 352,931 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $34,250,509 | 356,739 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $30,564,404 | 364,861 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $25,770,282 | 382,235 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $25,600,163 | 366,502 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $15,087,485 | 217,305 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,430,590 | 281,469 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $18,107,558 | 300,790 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||